Ultime notizie per TELA Bio (NASDAQ:TELA) Azioni

TELA Bio

TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.

TELA Bio Inc

Teladoc Health Inc

Earnings

News

DALN

DallasNews Q2 EPS $(6.26) Down From $0.27 YoY, Sales $29.766M Down From $32.061M YoY

Citizens Financial Servs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CZFS#NASDAQ">CZFS</a>) reported quarterly earnings of $1.76 per share which beat the analyst consensus estimate of $1.60 by 9.73 percent. The company reported quarterly sales of $27.31 million which beat the analyst consensus estimate of $23.30 million by 17.22 percent. This is a 10.87 percent increase over sales of $24.64 million the same period last year.

Earnings Beats

CZFS

Citizens Financial Servs Q2 EPS $1.76 Beats $1.60 Estimate, Sales $27.31M Beat $23.30M Estimate

TFS Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TFSL#NASDAQ">TFSL</a>) reported quarterly earnings of $0.08 per share which met the analyst consensus estimate. This is a 14.29 percent increase over earnings of $0.07 per share from the same period last year. The company reported quarterly sales of $82.042 million which beat the analyst consensus estimate of $76.799 million by 6.83 percent. This is a 8.64 percent increase over sales of $75.518 million the same period last year.

TFSL

TFS Financial Q3 EPS $0.08, Inline, Sales $82.042M Beat $76.799M Estimate

CVR Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVI#NYSE">CVI</a>) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $(0.00) by 5650 percent. This is a 355.56 percent decrease over earnings of $0.09 per share from the same period last year. The company reported quarterly sales of $1.761 billion which beat the analyst consensus estimate of $1.675 billion by 5.12 percent. This is a 10.47 percent decrease over sales of $1.967 billion the same period last year.

Earnings Misses

CVR Energy Q2 Adj. EPS $(0.23) Misses $(0.00) Estimate, Sales $1.761B Beat $1.675B Estimate

Buybacks

RenaissanceRe Holdings Authorizes Renewal Of Share Repurchase Program, Bringing The Total Current Authorization Up To $750.0M

Ford Motor Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) reported second-quarter financial results Wednesday after the close. Here&#8217;s a look at the key details<a href="https://www.benzinga.com/pressreleases/25/07/b46737351/ford-reports-second-quarter-2025-financial-results"> from the period</a>.
F stock is down in today&#8217;s after-hours session. <a href="https://www.benzinga.com/quote/F" target="_blank" rel="noreferrer noopener">Check the latest price here.</a>
Q2 Earnings: Ford reported second-quarter revenue of $46.94 billion, beating the&nbsp;<a href="http://benzinga.com/quote/F/earnings" target="_blank" rel="noreferrer noopener">consensus estimate</a>&nbsp;of $42.77 billion, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>. The Detroit-based automaker reported second-quarter adjusted earnings of 37 cents per share, beating estimates of 31 cents per share.
Total revenue was up 5% on a year-over-year basis. Here&#8217;s a breakdown of revenue by segment.
<ul class="wp-block-list">
<li>Ford Blue: $25.8 billion, down 3% year-over-year</li>
</ul>
<ul class="wp-block-list">
<li>Model e: $2.4 billion, up 105% year-over-year</li>
</ul>
<ul class="wp-block-list">
<li>Ford Pro: $18.8 billion, up 11% year-over-year</li>
</ul>
Ford ended the quarter with $23.02 billion in cash and cash equivalents. 
&#8220;Ford Pro is a unique competitive advantage driving both top and bottom-line growth while creating new high-margin revenue streams from software and physical services. Ford Blue delivered profitable market share gains, and we continue to improve the efficiency of our Ford Model e business,&#8221; said&nbsp;Jim Farley, president and CEO of Ford.
Guidance:&nbsp;Ford expects full-year 2025 adjusted EBIT of $6.5 billion to $7.5 billion, which includes a tariff headwind of about $2 billion. The company anticipates full-year adjusted free cash flow of $3.5 billion to $4.5 billion. Ford expects capital expenditures of approximately $9 billion in 2025.
&#8220;The net tariff-related headwind of about $2 billion reflects a $3 billion gross adverse adjusted EBIT impact, offset partially by $1 billion of recovery actions,&#8221; the company said.
Ford management will hold an earnings call to discuss the company&#8217;s quarterly results at 5 p.m. ET.
F Price Action: <a href="http://benzinga.com/quote/f" target="_blank" rel="noreferrer noopener">Ford shares</a> were down 4.42% in after-hours, trading at $10.39 at the time of publication on Wednesday, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/politics/25/07/46714902/trump-epa-wants-to-overturn-2009-endangerment-finding-that-controls-carbon-emissions-to-end-16-years-of-uncertainty-for-automakers">Trump EPA Wants To Overturn 2009 Endangerment Finding That Controls Carbon Emissions To End &#8217;16 Years Of Uncertainty For Automakers&#8217;</a></li>
</ul>
Photo: Tada Images/Shutterstock.com

Guidance

After-Hours Center

Movers

Ford Q2 Earnings: Revenue, EPS Beat Estimates, Shares Slide As Automaker Warns Of $2 Billion Tariff Headwind

First Horizon Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FHN#NYSE">FHN</a>) ("First Horizon" or "the Company") announced today its 2025 company-run capital stress test results. The 2025 test showed that, under hypothetical severe economic and business downturns, First Horizon would maintain capital ratios well above regulatory-required minimums. These internally generated results, which utilized the 2025 Dodd-Frank Act Stress Test Severely Adverse Scenario published by the Federal Reserve on February 5, 2025, reflect continued strong risk discipline.
"Our 2025 capital stress test results reflect the resilience of our diversified business model, prudent risk management, and strong capital position," said Chief Financial Officer Hope Dmuchowski. "Our minimum Common Equity Tier 1 Capital ratio of 9.7% is well above the required regulatory minimum of 4.5% and represents approximately $4 billion of additional pre-tax loss absorption capacity. These results demonstrate our ability to maintain safety and soundness and support clients across a broad range of economic scenarios with a near term target CET1 ratio of 10.75%."
The following table reflects the Company's actual and projected stressed capital ratios under the Federal Reserve's Severely Adverse Scenario compared to required regulatory minimums.

First Horizon Corporation Announces Results Of Its 2025 Company-Run Capital Stress Test Demonstrating That It Would Maintain Capital Ratios Well Above Regulatory Minimums

SciSparc Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPRC#NASDAQ">SPRC</a>) (the "Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, announces additional progress in connection with the proposed merger with AutoMax Motors Ltd., a leading vehicles importer and the exclusive importer of Anhui Jianghuai Automobile Group Corp., Ltd.-manufactured electric vehicles in Israel ("AutoMax").&nbsp;
As previously disclosed, in April 2024, SciSparc and AutoMax entered into a merger agreement, as amended, under which, SciSparc will acquire 100% of the share capital of AutoMax by way of a reverse merger between SciSparc Merger Sub Ltd., a wholly-owned subsidiary of the Company and AutoMax, with AutoMax surviving the merger as a wholly-owned subsidiary of the Company (the "Merger"). The closing of the Merger is subject to customary closing conditions, including shareholder approvals from both companies and Israeli court approval. The special meeting of SciSparc's shareholders to vote on the approval of the Merger will be held on&nbsp;August 25, 2025. The special meetings of AutoMax's shareholders and of AutoMax's shareholders who are not controlling shareholders or SciSparc, to vote on the approval of the Merger will be held on August 28, 2025.
On July 21, 2025, the U.S. Securities and Exchange Commission ("SEC") declared effective the registration statement on Form F-4 with respect to the Merger.

SPRC

SciSparc Advances Proposed Merger With AutoMax Motors; Shareholder Votes Set For Late August Following SEC Approval

OPOF

Old Point Financial Q2 EPS $0.24 Down From $0.50 YoY, Sales $15.428M Down From $15.587M YoY

The Board of Directors of Quaker Houghton (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KWR#NYSE">KWR</a>) today declared a $0.508 per share quarterly cash dividend, an increase of 4.7% over the prior dividend. &nbsp;The quarterly dividend is payable on October 31, 2025, to shareholders of record at the close of business on October 17, 2025.

Dividends

Quaker Houghton Increases Quarterly Cash Dividend From $0.48 To $0.508 Per Share

WIIM

QTWO

Q2 Holdings shares are trading higher after the company reported better-than-expected Q2 sales results, issued Q3 sales guidance above estimates, and raised its FY25 sales guidance.

Energy Capital Partners And KKR Announce Development Of 190 MW Hyperscale Data Center Campus

First US Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FUSB#NASDAQ">FUSB</a>) reported quarterly earnings of $0.03 per share. This is a 91.18 percent decrease over earnings of $0.34 per share from the same period last year. The company reported $10.32 million in sales this quarter. This is a 3.14 percent increase over sales of $10.01 million the same period last year.

FUSB

First US Bancshares Q2 EPS $0.03 Down From $0.34 YoY, Sales $10.32M Up From $10.01M YoY

Houston-based Calpine Corporation today announced a new 190-megawatt (MW) agreement with Dallas-based CyrusOne, a leading global data center developer and operator, to serve a new data center adjacent to the Thad Hill Energy Center in Bosque County, Texas. The deal secures power, grid connection, and land to support a new state of the art facility that is currently under construction and expected to be operational by the fourth quarter of 2026.&nbsp;

Calpine Signs 190MW Power Deal With CyrusOne To Support New Texas Data Center Launching In Late 2026

Orion S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OEC#NYSE">OEC</a>), a global specialty chemicals company, announced today the upcoming retirement of Jeff Glajch, its Chief Financial Officer, who intends to step down early in the fourth quarter of 2025.
"On behalf of our entire organization, we thank Jeff for his guidance and valuable contributions to Orion over the past three and a half years," Orion CEO Corning Painter said. "Thanks to Jeff's leadership, we have exceptional finance and IT teams in place, and we are well-positioned for future growth."
A comprehensive search will be launched to identify a successor. To ensure a smooth transition, Mr. Glajch will continue to support Orion through the end of 2025.
 &nbsp;

Management

Orion CFO Jeff Glajch To Retire In Q4 2025; Succession Search Underway

Albany International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIN#NYSE">AIN</a>) affirms FY2025 Adj EPS guidance from $3.00-$3.40 to $3.00-$3.40 vs $3.21 analyst estimate. Affirms FY2025 sales outlook from $1.17 billion-$1.26 billion to $1.17 billion-$1.26 billion vs $1.22 billion estimate.

Albany International Affirms FY2025 Adj EPS Guidance of $3.00-$3.40 vs $3.21 Est; Affirms FY2025 Sales Guidance of $1.17B-$1.26B vs $1.22B Est

Twin Hospitality Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWNP#NASDAQ">TWNP</a>) reported $87.846 million in sales this quarter. This is a 4.09 percent decrease over sales of $91.594 million the same period last year.

TWNP

Twin Hospitality Group Q2 Sales $87.846M Down From $91.594M YoY

Alkami Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALKT#NASDAQ">ALKT</a>) reported quarterly earnings of $0.09 per share which beat the analyst consensus estimate of $0.07 by 20 percent. This is a 80 percent increase over earnings of $0.05 per share from the same period last year. The company reported quarterly sales of $112.10 million which beat the analyst consensus estimate of $110.01 million by 1.90 percent. This is a 36.44 percent increase over sales of $82.16 million the same period last year.

ALKT

UPDATE: Alkami Technology Q2 Adj. EPS $0.09 Beats $0.07 Estimate, Sales $112.10M Beat $110.01M Estimate

Tronox Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TROX#NYSE">TROX</a>) narrows FY2025 sales outlook from $3.00 billion-$3.40 billion to $3.00 billion-$3.10 billion vs $3.07 billion estimate.

Comments

TELA Bio

Notizie

Ultime notizie per TELA Bio (NASDAQ:TELA) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO